Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-14

Clinical Trial Update: Cantharidin Application in Molluscum Patients-1 [Phase 3]

View source ↗

Summary

Phase 3 trial update for cantharidin application in Molluscum Contagiosum completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cantharidin application (cantharidin)

Snippet

Sponsor: Verrica Pharmaceuticals Inc. | Conditions: Molluscum Contagiosum | Phase 3 | Status: COMPLETED | Results posted: 2021-12-14